Your browser is no longer supported. Please, upgrade your browser.
LMAT LeMaitre Vascular, Inc. weekly Stock Chart
LMAT [NASD]
LeMaitre Vascular, Inc.
Index- P/E41.96 EPS (ttm)0.81 Insider Own15.50% Shs Outstand20.18M Perf Week5.12%
Market Cap669.41M Forward P/E35.27 EPS next Y0.96 Insider Trans-0.22% Shs Float16.83M Perf Month10.47%
Income16.50M PEG- EPS next Q0.19 Inst Own86.10% Short Float11.55% Perf Quarter31.24%
Sales114.70M P/S5.84 EPS this Y-20.80% Inst Trans0.24% Short Ratio14.93 Perf Half Y39.80%
Book/sh7.56 P/B4.48 EPS next Y30.08% ROA8.20% Target Price34.50 Perf Year-1.77%
Cash/sh1.27 P/C26.67 EPS next 5Y-1.80% ROE11.10% 52W Range18.76 - 38.64 Perf YTD-5.81%
Dividend0.38 P/FCF109.74 EPS past 5Y30.80% ROI11.80% 52W High-12.37% Beta1.34
Dividend %1.12% Quick Ratio1.20 Sales past 5Y10.50% Gross Margin67.70% 52W Low80.49% ATR1.14
Employees454 Current Ratio2.10 Sales Q/Q-15.60% Oper. Margin17.60% RSI (14)64.72 Volatility3.76% 3.34%
OptionableYes Debt/Eq0.42 EPS Q/Q-24.90% Profit Margin14.40% Rel Volume1.61 Prev Close33.45
ShortableYes LT Debt/Eq0.24 EarningsJul 23 AMC Payout42.60% Avg Volume130.28K Price33.86
Recom2.20 SMA205.59% SMA5011.35% SMA20015.04% Volume209,243 Change1.23%
Mar-16-20Upgrade Sidoti Neutral → Buy
Oct-24-19Upgrade Lake Street Hold → Buy $40
Oct-24-19Downgrade First Analysis Sec Strong Buy → Outperform $37 → $40
Oct-14-19Upgrade First Analysis Sec Outperform → Strong Buy $37
Jul-25-19Upgrade First Analysis Sec Neutral → Outperform $29 → $37
Jul-25-19Reiterated Barrington Research Outperform $32 → $37
Oct-08-18Upgrade ROTH Capital Neutral → Buy
Oct-08-18Upgrade Barrington Research Mkt Perform → Outperform $34
Jun-08-18Resumed ROTH Capital Buy $38
Apr-26-18Upgrade The Benchmark Company Hold → Buy $40
Apr-26-18Downgrade Stifel Buy → Hold $40 → $34
Oct-27-17Downgrade The Benchmark Company Buy → Hold
Oct-27-17Downgrade First Analysis Sec Overweight → Equal-Weight $34
Jul-10-17Downgrade The Benchmark Company Buy → Hold
Jul-10-17Downgrade Canaccord Genuity Buy → Hold $28
Mar-21-17Initiated First Analysis Sec Overweight $29
Feb-22-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-22-16Downgrade Sidoti Buy → Neutral
Jul-28-16Reiterated Barrington Research Outperform $18.50 → $20
Feb-25-16Reiterated Barrington Research Outperform $14 → $15.50
Sep-22-20 06:30PM  
05:46PM  
Sep-17-20 03:15AM  
Sep-16-20 09:47AM  
Aug-31-20 03:33PM  
Aug-21-20 06:49AM  
Jul-31-20 12:09PM  
Jul-30-20 04:28PM  
Jul-29-20 12:12PM  
Jul-28-20 06:45AM  
Jul-27-20 06:44AM  
Jul-26-20 10:58AM  
Jul-24-20 12:07PM  
Jul-23-20 07:15PM  
05:14PM  
04:25PM  
Jul-16-20 12:31PM  
Jul-10-20 03:11PM  
Jun-22-20 04:13PM  
Jun-12-20 04:28PM  
Jun-09-20 02:44PM  
Jun-01-20 05:30AM  
May-28-20 05:59PM  
May-20-20 03:56PM  
May-12-20 10:35AM  
May-05-20 08:36AM  
May-01-20 10:01PM  
Apr-30-20 08:25PM  
04:05PM  
Apr-23-20 12:32PM  
Apr-13-20 04:50PM  
Apr-09-20 09:22AM  
Mar-17-20 08:12AM  
Mar-04-20 11:07AM  
Feb-26-20 06:02AM  
Feb-18-20 12:28PM  
Feb-13-20 10:38AM  
06:44AM  
Feb-11-20 10:41AM  
Feb-10-20 09:28AM  
08:34AM  
Feb-09-20 08:42AM  
Feb-07-20 07:32AM  
Feb-06-20 06:25PM  
04:05PM  
Jan-30-20 12:31PM  
Jan-29-20 02:13PM  
Jan-26-20 05:36PM  
Jan-22-20 08:59AM  
Jan-10-20 05:00AM  
Jan-03-20 11:45AM  
Jan-02-20 02:12PM  
Dec-14-19 07:18PM  
Dec-09-19 12:46PM  
Nov-19-19 08:16AM  
Nov-15-19 06:35PM  
Nov-14-19 09:30AM  
Oct-30-19 08:34PM  
09:22AM  
Oct-29-19 04:26PM  
05:29AM  
Oct-23-19 05:25PM  
04:05PM  
Oct-16-19 10:32AM  
Oct-14-19 10:45AM  
Oct-13-19 07:00PM  
Oct-11-19 03:36PM  
Oct-02-19 09:30AM  
Sep-24-19 08:20AM  
Sep-13-19 09:15PM  
Sep-06-19 08:35AM  
Sep-05-19 07:17AM  
Sep-04-19 06:45AM  
Aug-27-19 08:56AM  
Aug-26-19 09:00AM  
Aug-23-19 08:37AM  
Aug-22-19 07:31AM  
Aug-20-19 09:03AM  
Aug-17-19 08:18AM  
Aug-14-19 09:33AM  
Aug-12-19 08:41AM  
Aug-09-19 07:32AM  
Aug-03-19 09:50AM  
Jul-30-19 12:29PM  
Jul-29-19 10:10AM  
Jul-26-19 06:15PM  
05:42AM  
Jul-25-19 07:21AM  
03:24AM  
Jul-24-19 06:15PM  
04:05PM  
Jul-17-19 10:32AM  
Jul-16-19 09:05AM  
Jul-11-19 05:27PM  
Jul-01-19 01:00PM  
Jun-28-19 07:56PM  
Jun-21-19 09:30AM  
Jun-13-19 10:28AM  
May-29-19 03:06PM  
01:43PM  
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. The company markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts David BPresident and DirectorAug 14Buy28.357,074200,51343,557Aug 17 08:56 AM
LeMaitre George WChairman and CEOJul 25Option Exercise0.008602,963,433Jul 28 09:37 PM
Pellegrino Joseph P JRChief Financial OfficerJul 25Option Exercise0.003107,111Jul 28 09:25 PM
Roberts David BPresident and DirectorJul 25Option Exercise0.0031036,752Jul 28 09:20 PM
Kamke Trent GSenior V. P., OperationsJul 25Option Exercise0.0012021,570Jul 28 09:12 PM
Kamke Trent GSenior V. P., OperationsJul 24Sale33.0013,804455,53221,558Jul 28 09:12 PM
O'Connor John JamesDirectorJul 21Option Exercise11.437,50085,72569,210Jul 23 06:15 PM
Roush John ADirectorJul 15Option Exercise11.437,50085,72527,500Jul 16 09:25 PM
LeMaitre George WChairman and CEOJul 08Option Exercise12.5723,621296,9162,963,347Jul 16 09:51 PM
Kamke Trent GSenior V. P., OperationsFeb 20Option Exercise11.4918,005206,87649,587Feb 24 04:01 PM
Kamke Trent GSenior V. P., OperationsFeb 20Sale31.0014,225440,97535,362Feb 24 04:01 PM
LeMaitre George WChairman and CEOJan 13Sale37.551,93972,80530,000Jan 15 05:49 PM
LeMaitre George WChairman and CEOJan 09Sale37.423,023113,13331,939Jan 09 05:55 PM
LeMaitre George WChairman and CEOJan 08Sale36.8112,440457,9202,939,726Jan 09 05:55 PM
LeMaitre George WChairman and CEOJan 07Sale36.6127,302999,5702,952,166Jan 09 05:55 PM
Pellegrino Joseph P JRChief Financial OfficerJan 03Sale36.073,231116,5557,080Jan 06 04:23 PM
Pellegrino Joseph P JRChief Financial OfficerJan 02Sale36.0771025,60710,311Jan 02 08:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 31Sale36.101,10539,89411,021Jan 02 08:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 30Sale36.116,265226,20012,126Dec 30 05:05 PM
LeMaitre George WChairman and CEODec 27Sale36.454,894178,3892,979,468Dec 31 05:41 PM
Pellegrino Joseph P JRChief Financial OfficerDec 27Sale36.219,748352,95618,391Dec 30 05:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 26Sale36.051,41250,90928,139Dec 30 05:05 PM
Pellegrino Joseph P JRChief Financial OfficerDec 24Sale36.0730010,82229,551Dec 26 10:48 AM
Kamke Trent GSenior V. P., OperationsDec 22Option Exercise0.004031,638Dec 26 11:17 AM
Roberts David BPresident and DirectorDec 22Option Exercise0.006036,841Dec 26 10:54 AM
Pellegrino Joseph P JRChief Financial OfficerDec 22Option Exercise0.006030,032Dec 26 10:48 AM
LeMaitre George WChairman and CEODec 22Option Exercise0.001602,984,884Dec 26 11:52 AM
Pellegrino Joseph P JRChief Financial OfficerDec 19Option Exercise0.005031,054Dec 23 08:20 PM
LeMaitre George WChairman and CEODec 19Option Exercise0.001702,980,450Dec 23 08:54 PM
Kamke Trent GSenior V. P., OperationsDec 19Option Exercise0.004030,897Dec 23 08:36 PM
Roberts David BPresident and DirectorDec 19Option Exercise0.005035,231Dec 23 08:28 PM
Pellegrino Joseph P JRChief Financial OfficerDec 19Sale36.052,785100,39728,264Dec 23 08:20 PM
Pellegrino Joseph P JRChief Financial OfficerDec 18Sale36.1010,442376,93331,049Dec 18 09:07 PM
Pellegrino Joseph P JRChief Financial OfficerDec 16Sale36.176,068219,50541,491Dec 18 09:07 PM
LeMaitre George WChairman and CEODec 16Sale36.404,759173,2382,980,433Dec 18 08:58 PM
Pellegrino Joseph P JRChief Financial OfficerDec 06Sale36.004,154149,54447,559Dec 09 04:43 PM
Pellegrino Joseph P JRChief Financial OfficerDec 05Sale36.002,796100,65651,713Dec 05 05:57 PM
LeMaitre George WChairman and CEODec 04Sale36.3211,241408,3002,985,192Dec 06 07:50 PM
Pellegrino Joseph P JRChief Financial OfficerDec 04Sale36.0067,7182,438,00454,509Dec 05 05:57 PM
Pellegrino Joseph P JRChief Financial OfficerDec 03Sale36.0050,6451,823,220122,227Dec 05 05:57 PM
Roberts David BPresident and DirectorNov 27Option Exercise11.436,90678,93642,132Nov 27 06:14 PM
Roberts David BPresident and DirectorNov 27Sale35.826,906247,34735,226Nov 27 06:14 PM
LeMaitre George WChairman and CEONov 26Sale36.252,906105,3472,996,433Nov 27 05:48 PM
Pellegrino Joseph P JRChief Financial OfficerNov 25Option Exercise12.5064,792810,195237,664Nov 27 05:41 PM
LeMaitre George WChairman and CEONov 25Sale36.1224,200874,0102,999,339Nov 27 05:48 PM
Pellegrino Joseph P JRChief Financial OfficerNov 25Sale35.8864,7922,324,478172,872Nov 27 05:41 PM
Pellegrino Joseph P JRChief Financial OfficerNov 22Option Exercise7.8725,945204,187198,817Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 22Sale35.0925,945910,387172,872Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 21Option Exercise7.875,74545,213178,617Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 21Sale35.015,745201,114172,872Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 20Option Exercise7.8711,18288,002184,054Nov 22 04:42 PM
Pellegrino Joseph P JRChief Financial OfficerNov 20Sale35.0111,182391,468172,872Nov 22 04:42 PM
LeMaitre George WChairman and CEONov 08Sale33.5316,051538,2003,024,394Nov 12 04:41 PM
LeMaitre George WChairman and CEONov 05Sale34.138,105276,6463,040,445Nov 05 06:35 PM
LeMaitre George WChairman and CEONov 04Sale34.505,519190,4243,048,550Nov 05 06:35 PM
LeMaitre George WChairman and CEONov 01Sale34.8614,684511,8463,054,069Nov 05 06:35 PM
LeMaitre George WChairman and CEOOct 31Sale35.541,79663,8213,068,753Oct 31 06:47 PM
LeMaitre George WChairman and CEOOct 30Sale35.539,921352,4913,070,549Oct 31 06:47 PM
LeMaitre George WChairman and CEOOct 29Sale35.599,217328,0173,080,470Oct 31 06:47 PM
Roberts David BPresident and DirectorOct 28Sale35.2912,202430,62735,226Oct 30 05:15 PM
LeMaitre George WChairman and CEOOct 28Sale35.537,348261,0653,089,687Oct 28 05:55 PM
LeMaitre George WChairman and CEOOct 24Sale37.177,068262,73234,962Oct 28 05:55 PM
Roberts David BPresident and DirectorOct 18Option Exercise8.7611,41999,99647,428Oct 22 05:40 PM